Tango公布Vopimetostat与Daraxonrasib联合治疗胰腺癌一期/二期研究积极数据,并更新开发策略

美股速递
Oct 23

Tango Therapeutics Inc. 公布了Vopimetostat与Daraxonrasib联合用于胰腺癌治疗的一期/二期研究取得的积极结果,同时对其后续开发战略作出最新调整。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10